Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Divergent memory responses driven by adenoviral vectors are impacted by epitope competition.

Colston JM. et al, (2019), Eur J Immunol, 49, 1356 - 1363

Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.

Atcheson E. et al, (2019), Hepatology

First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.

Cicconi P. et al, (2019), Clin Infect Dis

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.

Green CA. et al, (2019), J Infect, 78, 382 - 392

Single-cell transcriptome analysis of CD8 + T-cell memory inflation.

Highton AJ. et al, (2019), Wellcome Open Res, 4

Memory inflation following adenoviral vaccination depends on IL-21.

Gordon CL. et al, (2018), Vaccine, 36, 7011 - 7016

Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines.

Gordon CL. et al, (2018), Cell Rep, 23, 768 - 782

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.

von Delft A. et al, (2018), Vaccine, 36, 313 - 321

Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order.

Lee LN. et al, (2017), PLoS Pathog, 13

Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis.

Arnold IC. et al, (2015), Vaccine, 33, 1808 - 1814

Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis

Arnold IC. et al, (2015), Vaccine, 33, 1808 - 1814

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.

Beverley PCL. et al, (2014), J Immunol, 193, 2306 - 2316

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.

O'Hara GA. et al, (2012), J Infect Dis, 205, 772 - 781

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.

Porter DW. et al, (2011), Vaccine, 29, 7514 - 7522

Correction: Multiple functions of human T cells generated by experimental malaria challenge

Todryk SM. et al, (2011), European Journal of Immunology, 41

Multiple functions of human T cells generated by experimental malaria challenge.

Todryk SM. et al, (2009), Eur J Immunol, 39, 3042 - 3051

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Schmidt NW. et al, (2008), Proc Natl Acad Sci U S A, 105, 14017 - 14022

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

Thompson FM. et al, (2008), PLoS One, 3

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.

Hutchings CL. et al, (2007), Infect Immun, 75, 5819 - 5826

New insights into the altered adhesive and mechanical properties of red blood cells parasitized by Babesia bovis.

Hutchings CL. et al, (2007), Mol Microbiol, 65, 1092 - 1105

Load More